| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine (R.P.G., N.H.B.) and Pharmaceutical Sciences (K.S.P.), Medical University of South Carolina, Charleston, South Carolina 29425; and Department of Pharmacology and Toxicology (Y.A.H., J.R.H.), University of Texas Medical Branch, Galveston, Texas 77555-1031
Address all correspondence and requests for reprints to: Norman H. Bell, M.D., Department of Medicine, Medical University of South Carolina, Strom Thurmond Research Building, 114 Doughty Street, P.O. Box 250775, Charleston, South Carolina 29425. E-mail: belln{at}musc.edu.
Studies were performed to identify the microsomal enzyme that 24-hydroxylates vitamin D, whether 25-hydroxylation occurs, and structure function of the enzyme. Sixteen hepatic recombinant microsomal cytochrome P450 enzymes expressed in baculovirus-infected insect cells were screened for 24-hydroxylase activity. CYP3A4, a vitamin D-25-hydroxylase, and CYP1A1 had the highest 24-hydroxylase activity with 1
-hydroxyvitamin D2 (1
OHD2) as substrate. The ratio of rates of 24-hydroxylation of 1
-hydroxyvitamin D3 (1
OHD3), 1
OHD2, and vitamin D2 by CYP3A4 was 3.6/2.8/1.0. Structures of 24-hydroxyvitamin D2, 1,24(S)-dihydroxyvitamin D2, and 1,24-dihydroxyvitamin D3 were confirmed by HPLC and gas chromatography retention time and mass spectroscopy. In characterized human liver microsomes, 24-hydroxylation of 1
OHD2 by CYP3A4 correlated significantly with 6ß-hydroxylation of testosterone, a marker of CYP3A4 activity. 24-Hydroxylase activity in recombinant CYP3A4 and pooled human liver microsomes showed dose-dependent inhibition by ketoconazole, troleandomycin,
-naphthoflavone, and isoniazid, known inhibitors of CYP3A4. Rates of 24- and 25-hydroxylation of 1
OHD2 and 1
OHD3 were determined in recombinant wild-type CYP3A4 and site-directed mutants and naturally occurring variants expressed in Escherichia coli. Substitution of residues showed the most prominent alterations of function at residues 119, 120, 301, 305, and 479. Thus, CYP3A4 is both a 24- and 25-hydroxylase for vitamin D2, 1
OHD2, and 1
OHD3.
This article has been cited by other articles:
![]() |
R. P Heaney, L. A. Armas, J. R Shary, N. H Bell, N. Binkley, and B. W Hollis 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1738 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Prosser, Y. Guo, Z. Jia, and G. Jones Structural Motif-Based Homology Modeling of CYP27A1 and Site-Directed Mutational Analyses Affecting Vitamin D Hydroxylation Biophys. J., May 15, 2006; 90(10): 3389 - 3409. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, T. Hashizume, M. C. Shuhart, C. L. Davis, W. L. Nelson, T. Sakaki, T. F. Kalhorn, P. B. Watkins, E. G. Schuetz, and K. E. Thummel Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1{alpha},25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia Mol. Pharmacol., January 1, 2006; 69(1): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |